Califf Nomination For FDA Commish Could Reflect Bipartisan Appeal
This article was originally published in The Rose Sheet
After seven months as deputy commissioner for medical products and tobacco, Robert Califf has been tapped for FDA Commissioner.
You may also be interested in...
In an interview with “The Pink Sheet,” new deputy commissioner for medical products says FDA needs better ways of helping stakeholders, public understand agency thinking.
Acting FDA Commissioner says he can’t envision any new major priorities that would emerge in the short-term.
Renowned cardiologist and clinical trial researcher Robert Califf will join FDA in February as deputy commissioner for medical products and tobacco. Califf is director of Duke University’s Translational Medicine Institute and vice chancellor for Clinical and Translational Research.